Citation:Wong KH,Kam KW,Chen LJ,L A. Young.Corneal blindness and current major treatment concern-graft scarcity.Int J Ophthalmol 2017;10(7):1154-1162,doi:10.18240/ijo.2017.07.21 |
|
Corneal blindness and current major treatment concern-graft scarcity |
Received:June 04, 2016 Revised:September 26, 2016 |
Email this Article Add to Favorites Print |
DOI:10.18240/ijo.2017.07.21 |
Key Words:corneal blindness keratoplasty corneal graft corneal donation eye banking |
Fund Project: |
Author | Institution |
Kah Hie Wong |
Department of Ophthalmology and Visual Sciences, Chinese University of Hong Kong, Hong Kong, China |
Ka Wai Kam |
Department of Ophthalmology and Visual Sciences, Prince of Wales Hospital, Hong Kong, China |
Li Jia Chen |
Department of Ophthalmology and Visual Sciences, Chinese University of Hong Kong, Hong Kong, China; Department of Ophthalmology and Visual Sciences, Prince of Wales Hospital, Hong Kong, China |
Alvin L. Young |
Department of Ophthalmology and Visual Sciences, Chinese University of Hong Kong, Hong Kong, China; Department of Ophthalmology and Visual Sciences, Prince of Wales Hospital, Hong Kong, China |
|
Hits: 2032 |
Download times: 223 |
Abstract: |
According to World Health Organization, the global prevalence of blindness in 2010 was 39 million people, among which 4% were due to corneal opacities. Often, the sole resort for visual restoration of patients with damaged corneas is corneal transplantation. However, despite rapid developments of surgical techniques, instrumentations and immunosuppressive agents, corneal blindness remains a prevalent global health issue. This is largely due to the scarcity of good quality corneal grafts. In this review, the causes of corneal blindness, its major treatment options, and the major contributory factors of corneal graft scarcity with potential solutions are discussed. |
Supplementary Material |
PDF Fulltext Download reader View/Add Comment |
|
|
|
|